Show simple item record

dc.contributor.authorIbáñez Martínez, María
dc.contributor.authorMarcos, Josep
dc.contributor.authorVentura, Rosa
dc.contributor.authorSegura, Jordi
dc.contributor.authorPozo, Óscar J.
dc.contributor.authorTo-Figueras, Jordi
dc.date.accessioned2016-02-03T08:12:25Z
dc.date.available2016-02-03T08:12:25Z
dc.date.issued2015-07
dc.identifier.citationMARCOS, Josep, et al. Mass spectrometric characterisation of a condensation product between porphobilinogen and indolyl‐3‐acryloylglycine in urine of patients with acute intermittent porphyria. Journal of Mass Spectrometry, 2015, vol. 50, no 7, p. 929-937ca_CA
dc.identifier.issn1076-5174
dc.identifier.urihttp://hdl.handle.net/10234/147865
dc.description.abstractWe document the presence of a previously unknown species in the urine of patients with acute intermittent porphyria (AIP). Thecompound was fully characterised by liquid chromatography tandem mass spectrometry. Interpretation of both full spectrum ac-quisition and product ion spectra acquired in positive and negative ionisation modes by quadrupole time of flight MS allowed forthe identification of a condensation product arising from porphobilinogen (PBG, increased in the urine of AIP patients) andindolyl-3-acryloylglycine (IAG, derived from indolylacrylic acid and present in human urine). The structure was unequivocally con-firmed through comparison between the selected reaction monitoring chromatograms obtained from the urinary species and thecondensation product qualitatively synthesised in the laboratory. Owing to the large amounts of both PBG and IAG in urine of AIPpatients, the possible ex vivo formation of PBG-IAG in urine samples was evaluated. The product was spontaneously formed atroom temperature, at 4 °C and even during storage at 20 °C when spiking a control sample with PBG. A positive correlationwas found between PBG and PBG-IAG in samples collected from AIP patients. However, no correlation was found between PBG-IAG and IAG. Purified PBG-IAG did not form the characteristic chromogen after application of p-dimethylaminobenzaldehyde inHCl, thus suggesting that the current techniques used to measure PBG in urine of AIP patients based on Ehlrich’sreactiondonot detect this newly characterised PBG-IAG fraction.ca_CA
dc.format.extent9 p.ca_CA
dc.format.mimetypeapplication/pdfca_CA
dc.language.isoengca_CA
dc.publisherWileyca_CA
dc.relation.isPartOfJournal of Mass Spectrometry, 2015, vol. 50, no 7, p. 929-937.ca_CA
dc.rights© 2015 John Wiley & Sons, Ltd.ca_CA
dc.subjectmass spectrometryca_CA
dc.subjecturineca_CA
dc.subjectacute intermittent porphyriaca_CA
dc.subjectporphobilinogenca_CA
dc.subjectindolyl-3-acryloylglycineca_CA
dc.titleMass spectrometric characterisation of acondensation product betweenporphobilinogen and indolyl-3-acryloylglycinein urine of patients with acuteintermittent porphyriaca_CA
dc.typeinfo:eu-repo/semantics/articleca_CA
dc.identifier.doihttp://dx.doi.org/10.1002/jms.3603
dc.rights.accessRightsinfo:eu-repo/semantics/restrictedAccessca_CA
dc.relation.publisherVersionhttp://onlinelibrary.wiley.com/doi/10.1002/jms.3603/epdfca_CA


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record